- Home
- BDMD vs SLRN Comparison
BDMD vs SLRN Comparison
Compare BDMD & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDMD
- SLRN
- Stock Information
- Founded
- BDMD 2012
- SLRN 2020
- Country
- BDMD China
- SLRN United States
- Employees
- BDMD N/A
- SLRN N/A
- Industry
- BDMD
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- BDMD
- SLRN Health Care
- Exchange
- BDMD NYSE
- SLRN Nasdaq
- Market Cap
- BDMD 234.2M
- SLRN 197.6M
- IPO Year
- BDMD N/A
- SLRN 2023
- Fundamental
- Price
- BDMD $5.30
- SLRN $2.60
- Analyst Decision
- BDMD
- SLRN Hold
- Analyst Count
- BDMD 0
- SLRN 5
- Target Price
- BDMD N/A
- SLRN $9.60
- AVG Volume (30 Days)
- BDMD 172.6K
- SLRN 3.2M
- Earning Date
- BDMD 01-01-0001
- SLRN 03-27-2025
- Dividend Yield
- BDMD N/A
- SLRN N/A
- EPS Growth
- BDMD 578.78
- SLRN N/A
- EPS
- BDMD 0.43
- SLRN N/A
- Revenue
- BDMD $33,048,249.00
- SLRN N/A
- Revenue This Year
- BDMD N/A
- SLRN N/A
- Revenue Next Year
- BDMD N/A
- SLRN N/A
- P/E Ratio
- BDMD $12.42
- SLRN N/A
- Revenue Growth
- BDMD N/A
- SLRN N/A
- 52 Week Low
- BDMD $1.05
- SLRN $1.85
- 52 Week High
- BDMD $13.52
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- BDMD N/A
- SLRN 63.62
- Support Level
- BDMD N/A
- SLRN $2.08
- Resistance Level
- BDMD N/A
- SLRN $2.18
- Average True Range (ATR)
- BDMD 0.00
- SLRN 0.13
- MACD
- BDMD 0.00
- SLRN 0.11
- Stochastic Oscillator
- BDMD 0.00
- SLRN 94.97
About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.